The SLC16A2 gene plays a crucial role in transporting thyroid hormones, which are essential for normal brain development and metabolic regulation. Mutations in this gene can lead to disorders that impact neurological development and endocrine function, such as Allan-Herndon-Dudley syndrome, a rare condition linked to intellectual disability and motor skill challenges. Understanding the genetics behind such disorders aids endocrinologists and medical researchers in creating targeted treatment plans. For instance, early diagnosis of SLC16A2 mutations can inform therapeutic interventions aimed at managing thyroid hormone levels to support better neurodevelopmental outcomes. Moreover, studying the genetic basis of autism spectrum disorders (ASD), including childhood autism (#AutismoInfantil), provides insights into complex neurodevelopmental pathways. The interplay between genes like SLC16A2 and neuroendocrine factors contributes to the diverse presentation of ASD symptoms. As neurodevelopment research advances, interdisciplinary collaboration between geneticists and endocrinologists is vital. This approach fosters holistic understanding and improved management of genetic endocrine disorders affecting child development. Engaging in this expanding field offers promising opportunities for enhancing diagnostic tools and personalized treatment strategies that can significantly improve quality of life for affected individuals.